Keith Kaufman of Merck, senior director of clinical research in endocrinology and metabolism, presented 2 year study data on Propecia at the 1998 American Academy of Dermatology Conference. Dr. Kaufman showed slides detailing two year frontal (mid-anterior scalp, an area about 1 inch behind a normal hairline) results, including photographs of patients. Hair counts were shown to improve from around 10-11 additional haris per centimeter after one year to around 11-12 hairs per centimeter after two years, so results were maintained with slight improvement. Patients on placebo showed a sharp decrease in hairs in the first year. I am awaiting confirmation of exact numbers (a line graph was presented), but the decrease after one year was about 5 hairs per centimeter. After the first year, patients were placed on Propecia and showed an overall 8 hair increase per centimeter by the end of the second year, for a total of 3 hairs above baseline. The following table shows improvements judged by photographic analysis:
No patients in either group re rated as greatly improved. See example photos of Propecia study patients content2 |
|
More Info: Home | About Regrowth.com | How
to Advertise | Privacy Policy | Advertising
Policy | Contact Us
Site Map | Copyright © 2007
The Regrowth Network. All rights reserved. Legal Disclaimer
Other Cool Sites: Hair Loss Treatments - Body for Life Tracker - MedSpert
Propecia ® is
a registered trademark of Merck.
Avodart ® is a
registered trademark of GlaxoSmithKline.
Rogaine ® is a
registered trademark of Pfizer. Nizoral ® is
a registered trademark of McNeil Consumer & Specialty Pharmaceuticals.